MNKD Q4 2017 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena

MNKDMannKind Corporation

$841M

Q4 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M-63.5% YoY

Gross Profit

-$488,000-10.8% margin

Operating Income

-$29M-636.6% margin

Net Income

-$33M-723.7% margin

EPS (Diluted)

$-0.28

QoQ Revenue Growth

+121.7%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$30M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$85M

Total Liabilities

$299M

Stockholders' Equity

-$215M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$12M	-63.5%
Gross Profit	-$488,000	$621,000	-178.6%
Operating Income	-$29M	-$12M	-143.7%
Net Income	-$33M	$54M	-160.7%

Revenue Segments

Product

$3M100%